Evidence map›Paper›PMID 41019112›Full record

ArticleACS central science2025

The Martini 3 Lipidome: Expanded and Refined Parameters Improve Lipid Phase Behavior.

Kasper B Pedersen, Helgi I Ingólfsson, Daniel P Ramirez-Echemendia, Luís Borges-Araújo, Mikkel D Andreasen, Charly Empereur-Mot, Josef Melcr, Tugba N Ozturk, W F Drew Bennett, Lisbeth R Kjølbye and 20 more

Abstract read
In one paragraph

Article in ACS central science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Martini 3 Metabolome.Journal of chemical theory and computation · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Kasper B PedersenDepartment of Chemistry, Aarhus University, Langelandsgade 140, 8000 Aarhus C, Denmark.
Helgi I IngólfssonPhysical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California 94550, United States.ORCID https://orcid.org/0000-0002-7613-9143
Daniel P Ramirez-EchemendiaCentre for Molecular Simulation and Department of Biological Sciences, University of Calgary, 2500 University Dr. NW, Calgary, Alberta, Canada T2N 1N4.
Luís Borges-AraújoLaboratoire de Biologie et Modélisation de la Cellule, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, 46 Allée d'Italie, 69364, Lyon, France.ORCID https://orcid.org/0000-0003-3004-7750
Mikkel D AndreasenDepartment of Chemistry, Aarhus University, Langelandsgade 140, 8000 Aarhus C, Denmark.
Charly Empereur-MotDepartment of Innovative Technologies, University of Applied Sciences and Arts of Southern Switzerland, Polo Universitario Lugano, Campus Est, Via la Santa 1, 6962 Lugano-Viganello, Switzerland.ORCID https://orcid.org/0000-0001-6972-8225
Josef MelcrGroningen Biomolecular and Biotechnology Institute, Nijenborgh 7, 9747 AG Groningen, The Netherlands.
Tugba N OzturkPhysical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California 94550, United States.ORCID https://orcid.org/0000-0001-7225-9546
W F Drew BennettPhysical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California 94550, United States.ORCID https://orcid.org/0000-0003-3993-9077
Lisbeth R KjølbyePharmaceutical Sciences, AstraZeneca R&D Gothenburg, Mölndal, 431 83, Sweden.ORCID https://orcid.org/0000-0003-2834-3411
Christopher BrasnettGroningen Biomolecular and Biotechnology Institute, Nijenborgh 7, 9747 AG Groningen, The Netherlands.ORCID https://orcid.org/0000-0001-9235-1673
Valentina CorradiCentre for Molecular Simulation and Department of Biological Sciences, University of Calgary, 2500 University Dr. NW, Calgary, Alberta, Canada T2N 1N4.
Hanif M KhanCentre for Molecular Simulation and Department of Biological Sciences, University of Calgary, 2500 University Dr. NW, Calgary, Alberta, Canada T2N 1N4.
Elio A CinoCentre for Molecular Simulation and Department of Biological Sciences, University of Calgary, 2500 University Dr. NW, Calgary, Alberta, Canada T2N 1N4.ORCID https://orcid.org/0000-0002-7784-3896
Jackson CrowleyMolecular Microbiology and Structural Biochemistry (MMSB), UMR 5086 CNRS & Université de Lyon, Lyon 69367, France.
Hyuntae KimDepartment of Theoretical Biophysics, Max Planck Institute of Biophysics, Max-von-Laue Straße 3, 60438 Frankfurt am Main, Germany.
Balázs FábiánDepartment of Theoretical Biophysics, Max Planck Institute of Biophysics, Max-von-Laue Straße 3, 60438 Frankfurt am Main, Germany.
Ana C Borges-AraújoInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Av. da República, 2780-157 Oeiras, Portugal.ORCID https://orcid.org/0000-0002-9949-9125
Giovanni M PavanDepartment of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy.ORCID https://orcid.org/0000-0002-3473-8471
Guillaume LaunayLaboratoire de Biologie et Modélisation de la Cellule, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, 46 Allée d'Italie, 69364, Lyon, France.
Fabio LolicatoHeidelberg University Biochemistry Center, Heidelberg 69120, Germany.
Tsjerk A WassenaarGroningen Biomolecular and Biotechnology Institute, Nijenborgh 7, 9747 AG Groningen, The Netherlands.
Manuel N MeloInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Av. da República, 2780-157 Oeiras, Portugal.ORCID https://orcid.org/0000-0001-6567-0513
Sebastian ThallmairFrankfurt Institute for Advanced Studies, Ruth-Moufang-Str. 1, 60438 Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0002-3396-5840
Timothy S CarpenterPhysical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California 94550, United States.ORCID https://orcid.org/0000-0001-7848-9983
Luca MonticelliMolecular Microbiology and Structural Biochemistry (MMSB), UMR 5086 CNRS & Université de Lyon, Lyon 69367, France.ORCID https://orcid.org/0000-0002-6352-4595
D Peter TielemanCentre for Molecular Simulation and Department of Biological Sciences, University of Calgary, 2500 University Dr. NW, Calgary, Alberta, Canada T2N 1N4.ORCID https://orcid.org/0000-0001-5507-0688
Birgit SchiøttDepartment of Chemistry, Aarhus University, Langelandsgade 140, 8000 Aarhus C, Denmark.ORCID https://orcid.org/0000-0001-9937-1562
Paulo C T SouzaLaboratoire de Biologie et Modélisation de la Cellule, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, 46 Allée d'Italie, 69364, Lyon, France.ORCID https://orcid.org/0000-0003-0660-1301
Siewert J MarrinkGroningen Biomolecular and Biotechnology Institute, Nijenborgh 7, 9747 AG Groningen, The Netherlands.ORCID https://orcid.org/0000-0001-8423-5277

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipid membranes are central to cellular life. Complementing experiments, computational modeling has been essential in unraveling complex lipid-biomolecule interactions, crucial in both academia and industry. The Martini model, a coarse-grained force field for efficient molecular dynamics simulations, is widely used to study membrane phenomena but has faced limitations, particularly in capturing realistic lipid phase behavior. Here, we present refined Martini 3 lipid models with a mapping scheme that distinguishes lipid tails that differ by just two carbon atoms, enhancing the structural resolution and thermodynamic accuracy of model membrane systems including ternary mixtures. The expanded Martini lipid library includes thousands of models, enabling simulations of complex and biologically relevant systems. These advancements establish Martini as a robust platform for lipid-based simulations across diverse fields.

Identifiers

PMID41019112
PMCPMC12464760

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.